Chas Mckhann - Net Worth and Insider Trading
Chas Mckhann Net Worth
The estimated net worth of Chas Mckhann is at least $6 Million dollars as of 2024-11-13. Chas Mckhann is the President and CEO of Apollo Endosurgery Inc and owns about 643,826 shares of Apollo Endosurgery Inc (APEN) stock worth over $6 Million. Details can be seen in Chas Mckhann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chas Mckhann has not made any transactions after 2021-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chas Mckhann
Chas Mckhann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chas Mckhann owns 3 companies in total, including Intersect ENT Inc (XENT) , Apollo Endosurgery Inc (APEN) , and Silk Road Medical Inc (SILK) .
Click here to see the complete history of Chas Mckhann’s form 4 insider trades.
Insider Ownership Summary of Chas Mckhann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENT | Intersect ENT Inc | 2016-01-15 | Chief Commercial Officer |
| APEN | Apollo Endosurgery Inc | 2021-08-20 | director & President and CEO |
| SILK | Silk Road Medical Inc | 2023-11-02 | director & Chief Executive Officer |
Chas Mckhann Latest Holdings Summary
Chas Mckhann currently owns a total of 1 stock. Chas Mckhann owns 643,826 shares of Apollo Endosurgery Inc (APEN) as of August 20, 2021, with a value of $6 Million.
Latest Holdings of Chas Mckhann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APEN | Apollo Endosurgery Inc | 2021-08-20 | 643,826 | 10.00 | 6,438,260 |
Holding Weightings of Chas Mckhann
Chas Mckhann Form 4 Trading Tracker
According to the SEC Form 4 filings, Chas Mckhann has made a total of 2 transactions in Apollo Endosurgery Inc (APEN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Apollo Endosurgery Inc is the sale of 63,452 shares on August 20, 2021, which brought Chas Mckhann around $504,443.
Insider Trading History of Chas Mckhann
- 1
Chas Mckhann Trading Performance
Chas Mckhann Ownership Network
Ownership Network List of Chas Mckhann
Ownership Network Relation of Chas Mckhann
Chas Mckhann Owned Company Details
What does Intersect ENT Inc do?
Who are the key executives at Intersect ENT Inc?
Chas Mckhann is the Chief Commercial Officer of Intersect ENT Inc. Other key executives at Intersect ENT Inc include EVP & GC & Corporate Secretary Patrick A Broderick , Chief Human Resource Officer Reyna M Fernandez , and director & President and CEO Thomas A. West .
Intersect ENT Inc (XENT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intersect ENT Inc (XENT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intersect ENT Inc (XENT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intersect ENT Inc (XENT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intersect ENT Inc Insider Transactions
Chas Mckhann Mailing Address
Above is the net worth, insider trading, and ownership report for Chas Mckhann. You might contact Chas Mckhann via mailing address: 1555 Adams Drive, C/o Intersect Ent, Inc., Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
